Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia

By afschroeder • June 16, 2026

Zuckerman JE, Larson S, Abdelnour L. Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia. Kidney Med. 2026 May 12;8(7):101402. doi: 10.1016/j.xkme.2026.101402. PMID: 42290670; PMCID: PMC13254867.

Tags: Hematology/Oncology, HTRA1, IgA-lambda multiple myeloma, membranous nephropathy, Multiple myeloma, Nephrology, nephropathology, paraneoplastic membranous nephropathy, plasma cell dyscrasia HTRA1-associated membranous nephropathy, plasma cell neoplasm, polytypic IgG, progressive proteinuria, Publications, renal pathology

Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer

Mouabbi JA, Lipsyc-Sharf MD, Yan F. Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):1-16.[...]

Interpreting MRD results and integrating assays into practice

Lipsyc-Sharf MD. Interpreting MRD results and integrating assays into practice. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):7-11. PMID: 42283708.

Practical approach to MRD testing in breast cancer: Q&A

Mouabbi JA, Lipsyc-Sharf MD, Yan F. Practical approach to MRD testing in breast cancer: Q&A. Clin Adv Hematol Oncol. 2026 Jun;24(4 Suppl 4):11-15. PMID: 42283709.